Cite

HARVARD Citation

    Cabrales, P. et al. (2017). The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury. Expert review of hematology. 10 (6), pp. 575-582. [Online]. 
  
Back to record